Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Farma is an Indonesian state-owned biopharmaceutical company and the largest vaccine manufacturer in Southeast Asia. Established in 1890, the company provides a wide range of WHO-prequalified vaccines and antisera to over 150 countries, making it a vital player in global immunization efforts. Bio Farma is particularly recognized as a major global supplier of the Polio vaccine and has recently expanded its portfolio to include COVID-19 vaccines and diagnostic kits. As the parent company of Indonesia's state-owned pharmaceutical holding, it oversees major subsidiaries like Kimia Farma and Indofarma. The company continues to innovate through international partnerships and the development of new vaccine platforms to address emerging infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P.T. Bio Pharma.